Cyclin G was previously identi®ed as a target gene of the p53 tumor suppresser protein, and levels of cyclin G are increased after induction of p53 by DNA damage. However, the function of cyclin G has not been established. To determine the eect of increased expression of cyclin G, retroviruses encoding cyclin G were constructed and used to infect three dierent murine cell lines. Cyclin G protein levels induced by the retroviruses were within the range seen after DNA damage induction of p53. In each case we observed that such over-expression of cyclin G augments the apoptotic process. TNF-a induction of apoptosis is increased by expression of cyclin G in NIH3T3 ®broblasts which express p53, as well as in 10.1 ®broblasts which contain no p53 allele. Additionally, we observed that while cyclin G expression is markedly reduced upon aggregate formation in embryonic carcinoma P19 cells, retrovirus-mediated over-expression of cyclin G enhances apoptotic cell death in aggregated P19 cells, and increases the extent of apoptosis caused by retinoic acid or serum starvation of these cells. These data demonstrate that cyclin G plays a facilitating role in modulating apoptosis induced by dierent stimuli. Moreover, we have discovered that cyclin G expression is rapidly induced in P19 cells after exposure to Bone Morphogenic Protein-4 (BMP-4), suggesting that cyclin G may mediate apoptotic signals generated by BMP-4.
Introduction
Apoptosis, a universal genetic program of cell death in higher eukaryotes, may be essential for the prevention of tumor formation (Thompson, 1995) as well as normal development of dierentiating cells (Ra, 1992) . Cells which are not capable of undergoing the apoptotic response to genotoxic insults may evolve fullblown malignant tumors. Thus, dominant mutations in genes whose functions are inhibitory to apoptosis, or loss-of-function mutations in genes that are necessary for the execution of the apoptotic program, can cause the emergence of tumors. In fact, the products of many oncogenes, such as bcl-2 (Adams and Cory, 1998; Reed, 1997) or v-rel (White et al., 1995) , have antiapoptotic functions, and the inactivation of tumor suppresser proteins such as p53 leads to a diminished apoptotic response (Gottlieb and Oren, 1996; Ko and Prives, 1996) . Therefore, it is of central importance to understand the function of genes involved in apoptotic pathways, in order to elucidate the defense mechanisms of cells against tumorigenesis.
p53 is one of the most important tumor suppressor proteins (Levine, 1993) and more than 50% of human cancers contain mutated p53 (Hollstein et al., 1994) . The induction of p53 in many cell types leads to either cell cycle arrest or apoptosis (Gottlieb and Oren, 1996; Ko and Prives, 1996) , which is likely to contribute to the anti-tumor activity of p53. p53 functions as a sequence-speci®c transcription factor (Vogelstein and Kinzler, 1992) , and a number of downstream target genes of p53 have been identi®ed. Some of these, for example, Bax (Miyashita and Reed, 1995) or IGP-BP3 (Buckbinder et al., 1995) , can themselves induce apoptosis, presumably explaining at least in part how p53 can induce apoptosis.
It was previously demonstrated that cyclin G, which bears homology to members of the cyclin gene family, is one of the target genes of p53 (Okamoto and Beach, 1994; Zauberman et al., 1995) . Many cyclins have been shown to associate with catalytic partners, cyclindependent kinases (cdks), to comprise active kinase complexes. These cyclin-cdk kinase complexes exert profound eects on the progression of the cell cycle (Heichman and Roberts, 1994; Sherr, 1994) . However, the physiological or biochemical function(s) of cyclin G remains obscure so far. Cyclin G was shown to be associated with cdk5 in vivo (Kanaoka et al., 1997) , but it is not clear whether cyclin G acts as a regulatory subunit of cdk5. It was also demonstrated that cyclin G can associate with the B' regulatory subunit of protein phosphatase 2A (Okamoto et al., 1996) , as well as GAK, a non-cdk serine/threonine kinase (Kanaoka et al., 1997) . It is not yet known, however, whether cyclin G regulates the activity of these enzymes or serves as their substrate.
Although levels of cyclin G RNA remain constant throughout the cell cycle in actively cycling cells, immunohistochemcal studies have indicated that levels of cyclin G protein decrease to undetectable levels during mitosis (Tamura et al., 1993; Horne et al., 1996; Jensen et al., 1998) . It has been reported that overexpression of cyclin G promotes cell growth in the RKO colon carcinoma cell line, suggesting a positive role for cyclin G on the cell cycle (Smith et al., 1997) . However, it is not clear how this eect on cell cycle caused by cyclin G contributes to the activity of p53 as a tumor suppresser.
Here we demonstrate that the over-expression of cyclin G sensitizes cells to undergo apoptosis in three dierent mouse cell lines, NIH3T3 and 10.1 ®broblasts, and P19 embryonic carcinoma cells. The eect of cyclin G was observed when either the ®broblasts were exposed to TNF-a, or when P19 cells formed aggregates. Such eects on P19 aggregates were further enhanced after exposure of cells to retinoic acid (RA) or low serum. Further, we showed that BMP-4, a growth factor that is involved in dierentiation and which can induce apoptosis in neural tissues, induces cyclin G expression in aggregated P19 cells. Sensitization of cells to apoptosis mediated by cyclin G may contribute to the ability of p53 or BMP-4 to cause apoptosis, and thereby to suppress tumorigenesis.
Results
Retrovirus-mediated transfer of exogenous cyclin G into NIH3T3 and 10.1 cells
In order to gain insight into the biological role of cyclin G, a retrovirus expressing cyclin G was constructed and introduced into NIH3T3 cells and 10.1 ®broblast cells. These two ®broblast cell lines, both established from primary mouse embryo-derived ®broblasts by the`3T3' method, dier in their p53 status; NIH3T3 cells contain wild-type p53, whereas 10.1 cells are p53-null due to deletion of both p53 alleles (Harvey and Levine, 1991) . Cells were infected with either the retrovirus expressing cyclin G or the parental control virus, and infected cells were selected by neomycin drug resistance. Pools of infected cells were then used for the following experiments.
As expected, both NIH3T3 and 10.1 cells infected with the cyclin G-expressing retrovirus showed increased levels of cyclin G protein when compared to cells infected with the parental control virus ( Figure  1a and b, lanes 10 and 11). The levels of exogenouslyintroduced cyclin G protein in both cell types were comparable. Treatment of NIH3T3 with DNA-damaging agents induced endogenous cyclin G expression ( Figure 1a , lanes 1 ± 9). In contrast, similar treatment of 10.1 with DNA-damaging agents did not induce cyclin G expression (Figure 1b , lanes 1 ± 9), supporting previous observation that the induction of cyclin G is dependent on the presence of p53. Importantly, in NIH3T3 cells the level of exogenous cyclin G introduced by the retrovirus was comparable to, or less than, the level of endogenous cyclin G after treatment with DNA-damaging agents ( Figure 1a , lanes 1 ± 11). This indicates that the level of cyclin G protein achieved by retrovirus-mediated transfer is within the physiological range of expression of this protein.
Cyclin G sensitizes NIH3T3 and 10.1 cells to TNF-a-mediated apoptosis Since p53 can induce either apoptosis or cell cycle arrest in many types of cells, we attempted to determine if increased levels of cyclin G can cause either of these two outcomes. First, we examined if over-expression of cyclin G aects the cell cycle pro®le under normal growth conditions. Analysis of the DNA content of logarithmically growing cells by¯ow cytometry did not show any signi®cant dierences in cell cycle pro®le with or without cyclin G expression in either NIH3T3 or 10.1 cells (data not shown).
Next, we determined if cyclin G expression causes apoptosis. In normal growth conditions, less than 2% of NIH3T3 or 10.1 cells had sub-G1 DNA content either in the presence or absence of cyclin G overexpression (data not shown). Thus, introduction of cyclin G into these cells caused neither signi®cant cell cycle alteration nor apoptosis in these conditions. It has been reported that some gene products involved in apoptosis, such as cyclin D (Janicke et al., 1996; Sofer-Levi and Resnitzky, 1996) , myc (Evan et al., 1992; Janicke et al., 1994; Klefstrom et al., 1994) , or E1A (Chen et al., 1987; Lowe and Ruley, 1993) sensitize cells to undergo apoptosis in ®broblasts after treatment with TNF-a or serum starvation, but do not induce this process under normal growth conditions. We were interested in determining if cyclin G might have a similar role. It is well established that TNF-a is a potent inducer of apoptosis in many cell types (Ashkenazi and Dixit, 1998; Beyaert and Fiers, 1994) , and can initiate apoptosis in a p53-independent manner.
Therefore, the retrovirus-transformed NIH3T3 cells were treated with TNF-a in the presence of cycloheximide to induce apoptosis, and extents of apoptotic cell death were determined at various concentrations of TNF-a (Figure 2a) . It has been shown that apoptotic cells undergo characteristic morphological changes and, as a result, become detached from the substratum and lose cell-cell interactions (Wyllie et al, 1980) . Therefore trypan blue-negative cells which remained attached to plates were counted as surviving cells. Interestingly, at all concentrations of TNF-a, there were less surviving cells when cyclin G was expressed than in its absence (Figure 2a) . At the highest concentration of TNF-a (10 ng/ml), the number of surviving cells was reduced by 50% in the presence of cyclin G.
In order to determine if the decreased viability of the TNF-a-treated cyclin G-transformed cells was due to apoptosis, their DNA content was examined by¯ow cytometry and % of cells with sub-G1 amounts of DNA were measured. Treatment of cells with cycloheximide alone did not signi®cantly induce cells with sub-G1 DNA content in either the control or cyclin G retrovirus-infected NIH3T3 cells (Figure 2b ). If cells were treated with TNF-a in combination with cycloheximide, however, over-expression of cyclin G caused *40% increase of the number of cells with sub-G1 DNA (Figure 2b ), suggesting that the decreased viability of the cyclin G-transformed cells was due to the enhancement of apoptotic cell death.
The augmented apoptosis by cyclin G was further con®rmed by TUNEL analysis (Figure 2c ) (Gavrieli et al., 1992) . Neither of the transformed cells showed more than 2% TUNEL-positive cells when they were incubated with cycloheximide alone (Figure 2c ). On the other hand, 12.3% of the cyclin G-transformed cells were TUNEL-positive after 6 h treatment with 10 ng/ ml TNF-a, a *70% increase over-control cells under the same conditions ( Figure 2c ). Taken together, these results indicate that over-expression of cyclin G enhances the apoptotic response of NIH3T3 cells to TNF-a.
Although it has been shown that TNF-a-mediated apoptosis can occur in a p53-independent manner, it remained possible that the presence of wild-type p53 in NIH3T3 cells was required for the eect of added cyclin G. Accordingly, we examined if over-expression of cyclin G in 10.1 cells sensitizes cells to undergo TNF-a-mediated apoptosis ( Figure 2d ). We found that 10.1 cells are actually more sensitive to the combined treatment of cycloheximide and TNF-a than are NIH3T3 cells, and tend to die of apoptosis with earlier kinetics (data not shown). Therefore, the extent of apoptotic cell death was measured at 4 h after TNFa treatment. Here the eect on apoptosis by cyclin G expression in 10.1 cells was, in fact, more pronounced than in NIH3T3 cells, with cyclin G increasing by *70% the number of cells with sub-G1 DNA after TNF-a treatment ( Figure 2d ). Thus, these results indicate that cyclin G over-expression alone cannot induce apoptosis, but in conjunction with other inducers, leads to increased extents of cell death over that seen in its absence. Furthermore this eect of cyclin G does not require the presence or function of p53.
Next we attempted to determine if expression of cyclin G enhances apoptosis when cells receive other types of apoptotic signals. For that purpose, the transformed 10.1 cells were incubated in media containing low serum (0.5% FCS) for 24 h, and the increase of cells with sub-G1 DNA content was determined. After serum starvation, the numbers of apoptotic cells increased by *7% in both transformed cells, with no signi®cant increase by cyclin G overexpression (data not shown). Similarly we incubated transformed NIH3T3 cells in media containing low serum (0.5% calf serum) for 48 h, and determined the extent of apoptosis in these cells. Both transformed NIH3T3 cells were resistant to serum starvation, and showed less than 3% of cells with sub-G1 DNA content (data not shown). Thus, in mouse ®broblasts, cyclin G expression did not cause a signi®cant increase in apoptotic cells after serum starvation, although it augments signi®cantly apoptotic cell death caused by TNF-a in the presence of cycloheximide.
Down-regulation of endogenous cyclin G in P19 embryonic carcinoma cells after aggregate formation
We were interested in determining if cyclin G can aect the propensity of cells other than ®broblasts to undergo apoptosis. P19 mouse embryonic carcinoma cell lines were thus examined for this purpose. P19 is one of a number of mouse carcinoma cell lines which has the potential to dierentiate into a variety of cell (7) of 10 ng/ml TNF-a for 4 h, and the percentage of cells with sub-G1 DNA content was determined as described in (b) types (Rudnicki and McBurney, 1987) . For example, they are capable of dierentiating into neuron or muscle cells in the presence of either all-trans retinoic acid (RA) or DMSO, respectively, if they are grown under conditions where they can form aggregates (Rudnicki and McBurney, 1987) . Aggregates (otherwise known as embryoid bodies) are formed when cells are plated such that they cannot attach to the culture dish, i.e. when they are transferred to bacterial plates (Rudnicki and McBurney, 1987) . We ®rst examined the status of cyclin G in P19 cells. Unexpectedly, we found that endogenous expression of cyclin G protein in undierentiated P19 cells was high when cells were attached to plates under normal growth conditions, but was markedly decreased upon aggregate formation (Figure 3a) . This aggregationdependent down-regulation of cyclin G did not require exposure to RA (Figure 3a) .
To examine the eect of exogenously expressed cyclin G, P19 cells were infected and selected with either cyclin G or control retroviruses. The eect of cyclin G over-expression in P19 cells was determined when cells were subjected to conditions leading to aggregate formation. By 2 days after cells were exposed to such conditions, the levels of cyclin G protein in cyclin G-transformed cells were approximately *fivefold greater than those from cells infected with the control virus (Figure 3b ), but were still lower than that from undierentiated parental P19 cells (data not shown), suggesting again that the levels of cyclin G achieved after its overexpression by the retrovirus were within physiological range.
Initially, we determined if increased level of cyclin G causes alterations in the cell cycle pro®le of aggregated P19 cells. As seen with NIH3T3 and 10.1 cells, we did not observe any signi®cant dierences in cell cycle distribution when we compared the control and cyclin G-transformed cells (data not shown) suggesting that cyclin G expression does not signi®cantly aect the cell cycle in P19 cells when they are aggregated.
Cyclin G enhances apoptotic cell death in aggregated P19 cells mediated by a variety of stimuli Based on our observations with NIH3T3 and 10.1 cells, we tested whether cyclin G can enhance the apoptotic response of P19 cells to RA or serum starvation. After incubation with RA, both aggregates and supernatants were collected, and the extent of apoptotic cell death was determined using the Annexin V assay (Vermes et al., 1995) . Cyclin G-transformed P19 cells showed *50% increase in the number of apoptotic cells when compared to control cells, if aggregates were exposed to RA for 2 days (Figure 4a ). These results demonstrate that cyclin G enhances RAmediated apoptosis in aggregated P19 cells. In agreement with these observations, at 3 days after exposure to RA, cyclin G-transformed P19 cells showed approximately a two-fold decrease in the number of cells within aggregates when compared to control cells (data not shown). It has been demonstrated that after exposure to RA, apoptotic cells are excluded from aggregates, resulting in a decreased number of cells that form them (Ninomiya et al., 1997) . The observed decrease in the number of cyclin G-transformed cells in aggregates therefore further supports the conclusion that cyclin G enhances RAmediated apoptosis. Next, we determined if cyclin G expression in P19 augments apoptotic cell death induced by TNF-a. After incubation of transformed P19 aggregates with TNF-a in the presence of cycloheximide for 18 h, the extent of apoptotic cell death was determined by the Annexin V assay. Cyclin G-transformed cells showed *40% increase in apoptotic cells in this condition (data not shown), suggesting that TNF-a-mediated apoptosis was enhanced by cyclin G overexpression in P19 cells as well as in ®broblasts.
Finally, we examined if the over-expression of cyclin G enhances apoptotic cell death after cells were transferred to medium containing low concentrations of serum (Figure 4b and c) . Here we determined the eect of cyclin G overexpression on aggregated P19 cells while maintaining the cells in a high concentration of G418 (400 mg/ml), as we suspected that levels of introduced cyclin G protein may decrease without strong selective pressure in high G418 due to possible negative eects of cyclin G on cell growth. In contrast to 10.1 cells, cyclin G-transformed P19 cells incubated in low serum showed a 50*60% increase in the a b Figure 3 (a) Down-regulation of endogenous cyclin G protein upon aggregate formation in P19 cells. P19 cells were incubated in bacterial-grade dishes to facilitate aggregate formation either in the presence or the absence of 1 mM retinoic acid. Two days after aggregate formation, cells were incubated in fresh medium. Cells were harvested at day 0, 1, 2 and 4 after aggregate formation, and lysates from harvested cells were separated by 10% SDS ± PAGE and transferred to PVDF membrane. The membrane was then probed with anti-cyclin G antibody (upper panel) or anti-actin antibody (lower panel). (b) Expression of cyclin G in aggregated P19 cells after infection with cyclin G-expressing retrovirus. P19 cells were infected with either the cyclin G-expressing retrovirus or the control virus, and aggregates were formed either in the presence or the absence of RA as indicated. Lysates from aggregates of infected P19 cells were separated by 10% SDS ± PAGE, and transferred to a PVDF membrane. The membrane was probed with anti-cyclin G antibody (upper panel) or antiactin antibody (lower panel) (Figure 4b and c) . Remarkably, cyclin G-transformed cells in aggregates showed an *80% increase in the number of apoptotic cells even with normal concentration of serum, probably due to increased levels of exogenous cyclin G expression (Figure 4b and c) . Thus, cyclin G expression sensitized cells to undergo apoptosis in aggregates that were incubated in either normal or low cencentrations of serum.
Taken together, these results indicate that cyclin G expression in aggregated P19 cells enhances apoptotic cell death.
BMP-4 induces cyclin G expression in aggregated P19 cells
BMP-4, a member of a large family of signaling molecules known as the Transforming Growth Factorb (TGF-b) superfamily (Kingsley, 1994) , has been implicated in inducing apoptosis during neural development (Graham et al., 1994) . In P19 cells, it has been demonstrated that BMP-4 can induce apoptosis, and enhance RA-mediated apoptotic cell death (Glozak and Rogers, 1996) . We con®rmed that BMP-4 can induce apoptosis in aggregated P19 cells (data not shown). We were interested in determining if cyclin G is a downstream target of BMP-4 for two reasons: (i) as shown above cyclin G shows pro-apoptotic activity in aggregated P19 cells; (ii) it was reported that cyclin G is induced by a related family member, TGF-b (Horne et al, 1996) . Therefore, levels of cyclin G protein were examined in aggregated P19 cells after incubation with BMP-4 ( Figure 5 ). Western blot analysis indicated that cyclin G expression was markedly induced after incubation of cells with BMP-4 at protein level ( Figure 5, upper panel) . The kinetics of cyclin G induction were rapid, and a dramatic increase in cyclin G protein was observed within 1 h after exposure to BMP-4. Increased levels of cyclin G protein after incubation with BMP-4 were also observed in the presence of RA, although the extent of induction was somewhat lower compared to that in the absence of RA, presumably due to apoptotic cell death of cells that overexpress cyclin G (data not shown). Northern blot analysis indicated that cyclin G RNA levels were increased by threefold, 4 h after incubation with BMP-4 ( Figure 5 , lower panel), suggesting that induction of cyclin G expression by BMP-4 is at least partly regulated at the RNA level. These results indicate that cyclin G is a downstream target of BMP-4 in P19 cells. Taken together, our data supports strongly a signi®cant role for the p53 target gene, cyclin G, in mediating the process of apoptosis.
Discussion
It has been demonstrated that many members of the cyclin family play a crucial role in regulating the progression of cell cycle. Despite the intriguing link between the tumor suppresser protein, p53, and a potential regulator of the cell cycle, cyclin G, the biological signi®cance of the latter has remained elusive. In this paper, we demonstrate that cyclin G can sensitize cells to induce apoptosis in three dierent cell lines. Moreover, in aggregated P19 cells, cyclin G expression enhances apoptotic cell death, and sensitization by cyclin G was manifested upon exposure to dierent types of stimuli to induce apoptosis, namely TNF-a, RA, or low serum. Thus, cyclin G seems to play a general role in mediating apoptosis in aggregated P19 embryonic carcinoma cells.
Aggregate formation is a prerequisite for differentiation of P19 cells into a variety of tissues (Rudnicki and McBurney, 1987) . It may be possible that cells in such transition periods during development are highly sensitive to cyclin G-mediated apoptosis. Intriguingly, both p53 and BMP-4 are involved in inducing apoptosis during dierentiation (Almog and Rotter, 1997; Graham et al, 1994) . It will be interesting to determine if cyclin G mediates cell death signalling generated by these proteins during development.
It may be argued that ectopic over-expression of cyclin G does not re¯ect its true role de novo. However, comparison of cyclin G levels in cyclin G-transformed NIH3T3 cells with those in cells after treatment with DNA damaging agents demonstrated that the level of cyclin G after retrovirus transfer is within a physiological range, supporting the likelihood that the results obtained represent a bona ®de response to this p53 target.
Under normal conditions, without stimuli to induce apoptosis, we did not observe a signi®cant increase in cell death after expression of cyclin G. This shows that cyclin G can not induce the cell death program de novo, and rather functions to predispose cells to undergo apoptosis if induced by other signals. Put another way, cyclin G is not a initiator, but rather a facilitator of cell death. It is possible, however, that very high levels of cyclin G can actually induce apoptosis, and cells which express cyclin G at such high levels after retrovirus infection, may die of apoptosis during the neomycin selection period. It was reported that introduction of a cyclin G-GFP fusion proteins by DNA transfection induces apoptosis in primary hepatocytes (Jensen et al, 1998) . Thus, high levels of cyclin G achieved after DNA transfection may Figure 5 Induction of cyclin G expression by BMP-4 in P19 cells. P19 cells were incubated in bacterial-grade dishes to facilitate aggregate formation. Two days after aggregate formation, cells were incubated with BMP-4 (10 ng/ml) and harvested 1, 2, 4 or 24 h after incubation. Harvested cells were then used for Western blot analysis (upper panel) or Northern blot analysis (lower panel) to determine levels of cyclin G or actin induce apoptotic cell death even in the absence of apoptotic stimuli.
It is not clear how cyclin G expression sensitizes cells to undergo apoptosis at this moment. Two dierent mechanisms to induce apoptosis can be envisioned. First, cyclin G may enhance apoptotic cell death by altering the cell cycle. Although we did not detect signi®cant changes in cell cycle progression after cyclin G overexpression, it may be still possible that cyclin G causes subtle changes in cell cycle pro®le that are not detectable by conventional¯ow cytometry. Such alterations in some way may trigger the apoptotic program in cells that are susceptible to apoptosis. Second, cyclin G overexpression may sensitize cell to die of apoptosis by directly modulating the apoptotic program. For example, cyclin G may directly regulate levels or subcellular localizations of the key component(s) of apoptotic pathways, such as caspases or members of bcl-2 family.
It has been reported that another mammalian cyclin, cyclin D3, plays a similar positive role in inducing TNF-a-mediated apoptosis (Janicke et al., 1996) . Cyclin D3, a member of the G1 cyclin family, plays a positive role in the cell cycle, and yet can augment the apoptotic response to TNF-a (Janicke et al., 1996) . It will be interesting to determine if cyclin G shares common pathways with cyclin D3 in facilitating apoptosis.
The results from 10.1 cells in Figure 2d show that cyclin G over-expression sensitizes cells to undergo apoptosis in the absence of wild-type p53. This suggests that cyclin G can enhance p53-independent apoptotic signals generated by TNF-a. In addition to enhancement of p53-independent apoptosis, cyclin G may contribute to p53-dependent apoptosis. It is clearly established that p53 can trans-activate cyclin G in a wide variety of cell lines (Bates et al., 1996; Okamoto and Beach, 1994; Zauberman et al., 1995; Okamoto et al, data not shown) . It is thus possible that cyclin G co-operates with other p53 target genes to increase the extent of apoptosis after the activation of p53. It has been reported that Bax, another target of p53, needs to synergize with other activities controlled by p53 to induce a full p53-dependent apoptotic response (McCurrach et al., 1997) . However, we have been unable to demonstrate a cooperative eect between cyclin G and either Bac or p21 to induce apoptosis in transient transfection assays (data not shown).
We have previously shown that cyclin G interacts with the regulatory subunit of protein phosphatase 2A (PP2A) (Okamoto et al., 1996) . It was reported that okadaic acid, an inhibitor of PP2A, can induce apoptosis in many cell lines (Gjertsen and Doskeland, 1995) . It is attractive to speculate that PP2A may inhibit cyclin G, and that the inactivation of PP2A by okadaic acid leads to the induction of apoptosis. Experiments to examine this hypothesis are underway.
BMP-4 has been shown to be an important regulator of cell fate decision, and can induce apoptosis in neural tissue during development (Graham et al, 1994) . Notably, BMP-4 can induce apoptosis in aggregated P19 cells (Glozak and Rogers, 1996, Figure 5a (Figure 5b ) suggests that cyclin G may be an immediate early response gene in BMP-4 signaling pathways. Further, combined with the ability of BMP-4 and cyclin G to induce apoptosis, these observations lead to a potential role of cyclin G as a signal molecule that mediates the induction of apoptosis by BMP-4. It is likely that induction of cyclin G expression by BMP-4 is independent of p53, since levels of p53 protein did not change signi®cantly after incubation of aggregated P19 cells with BMP-4 (data not shown). It is tempting to imagine that p53 and BMP-4 apoptotic pathways converge on cyclin G induction to exert either tumor suppressor activities or developmental programs.
Materials and methods

Plasmid construction
pMND-X-SN, the parental retrovirus vector, contains modi®ed LTRs that are active in embryonic carcinoma cells (Robbins et al., 1997) . To construct the cyclin G-expressing retrovirus vector, pMND-cycG-SN, the EcoRI ± BamHI fragment containing the complete open reading frame of cyclin G was inserted into the same sites in the pMND-X-SN.
Cells
P19 cells were maintained in alpha-Modi®ed Eagle Medium (aMEM) supplemented with 10% fetal calf serum. Retrovirus-transformed P19 cells were selected and maintained in aMEM supplemented with 20% fetal calf serum.
Induction of aggregate formation of P19 cells was performed as previously described before (Rudnicki and McBurney, 1987) . P19 cells were plated in bacterial-grade dishes at the density of 1610 5 cells/ml. NIH3T3 cells and 10.1 cells were maintained in Dulbecco's Modi®ed Eagle Medium (DMEM) supplemented with 10% calf serum. Retrovirus-transformed NIH3T3 cells were selected and maintained in the same medium.
Retrovirus-mediated gene transfer
In order to produce ecotropic viruses, the BOSC 23 packaging cell line (Pear et al., 1993) was transfected by the calcium phosphate precipitation method. Transformation of P19 cells and NIH3T3 cells was achieved by infection with the parental or the cyclin G-expressing retrovirus vectors in the presence of 4 mg/ml polybrene.
Infected P19 cells were selected in medium containing 400 mg/ml G418 (Gibco ± BRL) for approximately 10 days, and maintained in medium containing 200 mg/ml G418. In experiments performed in Figure 4b , infected cells were maintained in medium containing 400 mg/ml G418. Infected NIH3T3 and 10.1 cells were selected in medium containing 500 mg/ml G418 for 6 days, and maintained in medium containing 200 mg/ml G418. Selected cells were used for experiments immediately.
Analysis of apoptosis in NIH3T3 cells and 10.1 cells
In order to induce apoptosis in NIH3T3 and 10.1, cells were plated at 2610 5 cells per 35 mm-plate for 1 day, incubated with 10 mg/ml cycloheximide for 30 min, and then incubated with human TNF-a (Boehringer) in the presence of 10 mg/ml cycloheximide.
For viability assays, adherent cells were washed once with PBS, and trypsinized for 5 min. Trypsinized cells were analysed for viability by trypan blue exclusion.
To determine the DNA content of cells, non-adherent and trypsinized adherent cells were pooled, washed once in PBS, and ®xed in 90% methanol for overnight. Fixed cells were then washed twice in PBS, incubated in PBS containing 2% calf serum, 25 mg/ml propidium iodide and 50 mg/ml RNaseA for 30 min. Subsequently, the DNA content of cells was determined by¯ow cytometry (Facscan, Becton Dickinson).
For TUNEL assays, non-adherent and trypsinized adherent cells were pooled, washed once with PBS, suspended in PBS containing 1% BSA, and ®xed in 1% methanol-free formaldehyde (Polyscience) at 48C for 20 min. Fixed cells were washed twice with PBS containing 1% BSA, and incubated in 75% ethanol at 7208C overnight. Subsequently, cells were washed twice with PBS containing 1% BSA, and labeled with 5 mM¯uorescein-12-dUTP in 50 ml of 16terminal deoxynucleotidyltransferase (TdT) buer (Promega) and 25 units of TdT for 1 at 378C according to the manufacturer's instruction (Promega). Labeled cells were washed three times with 0.1% Triton X-100 in PBS containing 2% calf serum, and suspended in PBS containing 2% calf serum, 5 mg/ml propidium iodide, and 250 mg/ml RNaseA. Incorporation of the labeled dUTP in cells was analysed by¯ow cytometry.
Analysis of apoptosis in P19 cells
In order to induce apoptosis in aggregated P19 cells with RA, cells were plated in bacterial-grade dishes in aMEM containing 1 aM RA for 48 h. To induce apoptosis by low serum, P19 cells were initially plated in bacterial-grade dishes in a-MEM supplemented with 20% fetal calf serum for 24 h, and aggregates were collected by centrifugation at 200 g for 5 min. Aggregates were then washed once in serum-free medium, and incubated in bacterial-grade dishes in medium supplemented with 1% fetal calf serum for 24 h.
For Annexin V staining assay of aggregated P19 cells, both cells in aggregates and apoptotic cells excluded from aggregates were collected by centrifugation at 1000 g for 10 min, washed once with PBS, and trypsinized for 10 min at 378C. Trypsinzed cells were then washed once in PBS containing 2% calf serum, and incubated in 100 ml of Annexin V binding buer (10 mM HEPES (7.4), 140 mM NaCl, 5 mM CaCl 2 ) with 5 ml of Annexin V (Boehringer) and 1 mg/ml propidium iodide (PI) for 5 min. PI-negative/ Annexin V-positive cells were counted as apoptotic cells bȳ ow cytometry.
Western blot analysis
Harvested cells were washed three times with PBS, and lysed in RIPA buer (50 mM Tris (pH 7.5), 250 mM NaCl, 1% Nonidet P-40, 0.5% DOC, 0.1% SDS, 50 mM NaF, 1 mM Na 3 VO 4 , 0.5 mM phenylmethylsulfonyl¯uoride, 10 mg/ml leupeptin, 1 mg/ml pepstatin, 10 mg/ml aprotinin, 1 mM benzamidine, 10 mg/ml trypsin inhibitor). Lysates were centrifuged at 14 000 g for 10 min, supernatants were separated by 10% SDS ± PAGE, and transferred to a PVDF membrane (Millipore). The membrane was blocked with 5% nonfat dried milk in TBST buer (10 mM Tris (pH 7.5), 150 mM NaCl, 0.1% Tween-20), and then probed with the puri®ed antibodies against N-terminal domain of cyclin G (Okamoto et al., 1996) . The detection of the bound anticyclin G antibody was performed as described previously (Okamoto et al., 1996) .
Northern blot analysis
Northern blot analysis was performed as described before (Okamoto and Beach, 1994) .
